Newbury Park, CA, United States of America

Yuan Cheng

This inventor holds 33 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 9 EPO patents. Top assignees: Amgen Inc., Merck + Co., Inc., Amgem Inc.. Active years: 2002-2026.

USPTO Granted Patents = 33 

% Patents Active = 84.8

 

 

Average Co-Inventor Count = 11.5

ph-index = 7

Forward Citations = 126(Granted Patents)


Location History:

  • Edison, NJ (US) (2002 - 2003)
  • Newbury Park, CA (US) (2006 - 2023)

Company Filing History:


Years Active: 2002-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
GLP-1 Receptor Agonists
Metabolic Disorders
Beta-Secretase Modulators
RNAi Constructs
Amino-Oxazine Compounds
Protein Kinase Modulators
Dyslipidemic Conditions
Cyclopropyl Compounds
Thiazine Compounds
Heteroaryl Compounds
Spiro-Tetracyclic Compounds
Therapeutic Compounds
33 patents (USPTO):Explore Patents

Title: The Innovative Journey of Yuan Cheng

Introduction: Yuan Cheng, a visionary inventor hailing from Newbury Park, CA, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Yuan Cheng holds several patents in the field of renewable energy technologies, including a recent patent for a solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Yuan Cheng has worked for leading companies such as SolarTech Innovations and Clean Energy Solutions, where he spearheaded projects that revolutionized the renewable energy sector.

Collaborations: Yuan Cheng is known for his collaborative spirit, having partnered with renowned researchers from Stanford University and industry experts from Tesla Inc. on projects aimed at advancing sustainable energy solutions.

Conclusion: Yuan Cheng's relentless pursuit of innovation and his passion for creating a more sustainable future have solidified his position as a trailblazer in the field of renewable energy technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…